Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

305
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

290
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
290
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

622
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
622
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

883
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
883
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

694
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
694
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

1.0K
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mean arterial pressure-to-norepinephrine-equivalent dose ratio, rather than achieved mean arterial pressure alone, is associated with mortality in septic shock.

Journal of intensive care·2026
Same author

The authors reply.

Critical care medicine·2025
Same author

Comparison of appropriate antimicrobial monotherapy and combination therapy in patients with carbapenem-resistant gram-negative bacilli bloodstream infections: a multicenter retrospective cohort study.

Microbiology spectrum·2025
Same author

Population-wise incidence and outcomes of patients requiring invasive and non-invasive mechanical ventilation in China: a nationwide retrospective analysis by age, sex, and comorbidity.

Annals of intensive care·2025
Same author

Association Between Mechanical Power During Prone Positioning and Mortality in Patients With Acute Respiratory Distress Syndrome.

Critical care medicine·2025
Same author

The authors reply.

Critical care medicine·2025

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Enhancing PSC-to-Functional Cell Differentiation Using ML Models Based on Live-Cell Bright-Field Imaging
11:38

Author Spotlight: Enhancing PSC-to-Functional Cell Differentiation Using ML Models Based on Live-Cell Bright-Field Imaging

Published on: October 4, 2024

1.2K

A Machine Learning-Based Model for Individualized Prediction of Vancomycin Concentration-Time Curves in ICU Patients.

Jing-Yi Wang1,2, Jiang Hu1,3, Yan Chen1

  • 1Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.

Pharmacology Research & Perspectives
|March 10, 2026
PubMed
Summary

A new machine learning model accurately predicts vancomycin concentrations in intensive care unit (ICU) patients. This tool optimizes vancomycin dosing for improved patient safety and treatment efficacy.

Keywords:
critical caremachine learningtherapeutic drug monitoringvancomycin

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.7K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Enhancing PSC-to-Functional Cell Differentiation Using ML Models Based on Live-Cell Bright-Field Imaging
11:38

Author Spotlight: Enhancing PSC-to-Functional Cell Differentiation Using ML Models Based on Live-Cell Bright-Field Imaging

Published on: October 4, 2024

1.2K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.7K

Area of Science:

  • Pharmacology
  • Machine Learning
  • Critical Care Medicine

Background:

  • Therapeutic drug monitoring is crucial for vancomycin efficacy and safety in critically ill patients.
  • Individualized dosing is challenging due to pharmacokinetic variability in intensive care unit (ICU) settings.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting vancomycin concentration-time curves in ICU patients.
  • To create a practical decision-support tool for optimizing vancomycin dosage.

Main Methods:

  • Retrospective analysis of adult ICU patients receiving intravenous vancomycin.
  • Development of a predictive model integrating Lasso Regression and LightGBM with a pharmacokinetic model.
  • Bayesian posterior inference used for estimating individual pharmacokinetic parameters.

Main Results:

  • The machine learning model achieved a mean absolute percentage error (MAPE) of 39.5% in internal validation and 35.6% in external validation.
  • The model significantly outperformed traditional pharmacokinetic models (p < 0.001).
  • A user-friendly software tool was developed for clinical application.

Conclusions:

  • The proposed machine learning model provides a robust and practical approach for individualized vancomycin dosing in ICU patients.
  • This decision-support tool can enhance vancomycin therapy management, improving patient outcomes.